Irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin

J Natl Cancer Inst. 1998 Jan 21;90(2):160. doi: 10.1093/jnci/90.2.160.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abdominal Pain / chemically induced
  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Atropine / therapeutic use
  • Blood Pressure / drug effects
  • Camptothecin / adverse effects
  • Camptothecin / analogs & derivatives*
  • Camptothecin / therapeutic use
  • Cholinergic Fibers / drug effects*
  • Colorectal Neoplasms / drug therapy*
  • Female
  • Humans
  • Irinotecan
  • Middle Aged
  • Organoplatinum Compounds / adverse effects*
  • Organoplatinum Compounds / therapeutic use
  • Oxaliplatin
  • Parasympatholytics / therapeutic use
  • Salivation / drug effects
  • Topoisomerase I Inhibitors*

Substances

  • Antineoplastic Agents, Phytogenic
  • Organoplatinum Compounds
  • Parasympatholytics
  • Topoisomerase I Inhibitors
  • Oxaliplatin
  • Irinotecan
  • Atropine
  • Camptothecin